A new report published by Turning Point titled “A Sobering Thought”, spotlights the devastating impact of alcohol-related harm and calls for urgent action to address the issue. On this report, FibroScan® is highlighted for early detection of liver disease in primary and community care settings and improved access to testing for underserved groups.